CHIME, AMDIS, more 'implore' HHS to amend 2015 EHR reporting period

Several professional associations have banded together to call for immediate action to amend the 2015 EHR reporting period. In a letter to Dept. of Health & Human Services (HHS) Secretary Sylvia M. Burwell, the College of Healthcare Information Management Executives (CHIME), the Association of Medical Directors of Information Systems (AMDIS) and 15 other healthcare organizations issued an immediate call to action to adjust the 2015 EHR reporting period to help hundreds of thousands of providers meet Meaningful Use (MU) Stage 2 requirements safely and effectively. Responding to the Centers for Medicaid & Medicare Services' (CMS) final rule on MU flexibility, the letter states the agency's decision to require a full-year of reporting using 2014 Edition certified EHR technology (CEHRT) in 2015 "puts many eligible hospitals and physicians at risk of not meeting MU next year and hinders the forward trajectory of the program," according to a release. "We implore you to take immediate action by shortening the 2015 EHR reporting period to 90 days and by adding flexibility in how providers meet the Stage 2 requirements," the letter states. "The additional time and flexibility afforded by these modifications will help hundreds of thousands of providers meet Stage 2 requirements in an effective and safe manner. This will reinforce investments made to date and it will ensure continued momentum towards the goals of Stage 3, including enhanced care coordination and interoperability." While the final rule does provide flexibility in meeting MU requirements for 2014, most hospitals who take advantage of the new pathways will not be in a position to meet Stage 2 requirements beginning October 1, 2014 (FY 2015). "With just two weeks to go before the start of Fiscal Year 2015, immediate attention to this requirement is essential," said CHIME President and CEO Russell P. Branzell, FCHIME, CHCIO. "There are thousands of hospitals right now desperately trying to determine how to appropriately install and configure software for Stage 2, and how to start collecting data by the end of this month." The letter outlines that to date; only 143 hospitals have met Stage 2, representing a very small percentage of the 3,800 hospitals required to be Stage 2-ready within the next 14 days. "This additional time is vitally important to ensure that hospitals and physicians continue moving forward with technology to improve patient care," the letter states. "By making such changes, HHS would improve patient safety, without compromising momentum towards interoperability and care coordination supported by health IT." By adjusting the timeline, providers would have the option to choose any three-month quarter for an EHR reporting period in 2015 to qualify for Meaningful Use. "This sensible change to the 2015 reporting period, from 365 days to 90, will ensure broad program participation and will enable providers to continue their Meaningful Use journey," said CHIME Board Chair Randy McCleese FCHIME, LCHIME, CHCIO, Vice President of Information Services and CIO at Morehead, Kentucky-based St. Claire Regional Medical Center. "Carrying forward the 2014 policy requiring providers submit data covering one quarter of their choosing in 2015 is the right decision, and it is our hope that officials act quickly." CHIME leaders will reiterate this call to action as they meet with officials this week as part of National Health IT Week in Washington, D.C. 
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.